ALLERGIC DISEASE
Clinical trials for ALLERGIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC DISEASE trials appear
Sign up with your email to follow new studies for ALLERGIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New allergy drug Exl-111 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage trial is testing the safety of a new drug called Exl-111 in 70 healthy volunteers. The study has two parts: one where people get a single dose, and another where they get multiple doses. Some participants will receive the drug, some a placebo, and some an existin…
Matched conditions: ALLERGIC DISEASE
Phase: PHASE1 • Sponsor: Excellergy Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New study probes why some babies develop eczema: Self-Antibodies under the microscope
Knowledge-focused Recruiting nowThis study looks at whether babies born with certain self-reactive antibodies are more likely to develop eczema. Researchers will test umbilical cord blood from 500 newborns—some with a family history of allergies or eczema, some without—and follow them for two years. The goal is…
Matched conditions: ALLERGIC DISEASE
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC